C. Srinroch, et al.
PhytochemistryLetters30(2019)205–209
3. Experimental
Table 1
1H and 13C NMR spectroscopic data of compound 1 (in CD3OD).
3.1. General procedures
Position
1
δH
δC
NMR spectra were recorded in CD3OD using a Bruker AV-400
(400 MHz for 1H-NMR and 100 MHz for 13C-NMR) spectrometer. The
MS data was obtained on a Bruker Micro TOF-LC mass spectrometer.
Optical rotations were measured with a Jasco P-1020 digital polari-
meter. For column chromatography, Diaion HP-20 (Mitsubishi
Chemical Industries Co. Ltd.), silica gel 60 (230–400 mesh, Merck), and
RP-18 (50 μm, YMC) were used. HPLC (Shimadzu LC-10AT pump) was
carried out on an ODS column (21.2 x 250 mm i.d., Vertisep™UPS) with
a Jasco UV-970 detector at 210 nm. The flow rates were 6 ml/min. The
spraying reagent used for TLC was 10% H2SO4 in H2O-EtOH (1:1, v/v).
Aglycone
1
138.5
130.0
129.3
128.9
71.9
2, 6
3, 5
4
7.41 (2H, dd, J = 8.3, 1.3 Hz)
7.33 (2H, td, J = 8.3, 1.3 Hz)
7.28 (1H, dd, J = 7.2, 1.3 Hz)
4.93(1H, d, J = 11.0 Hz)
7
4.62 (1H, d, J = 11.0 Hz)
Glc
1'
4.45 (1H, d, J = 7.8 Hz)
101.6
79.2
88.3
70.1
77.5
62.7
2'
3.56 (1H, dd, J = 8.9, 7.8 Hz)
3.67 (1H, dd, J = 8.9, 8.8 Hz)
3.43 (1H, dd, J = 9.6, 8.8 Hz)
3.29 (1H, m)
3'
4'
3.2. Plant material
5'
6'
3.91 (1H, dd, J = 12.2, 2.0 Hz)
3.71 (1H, dd, J = 12.2, 5.9 Hz)
The leaves of Magnolia sirindhorniae Noot. & Chalermglin were
collected from Lopburi Province, Thailand, in December 2017. Plant
specimen was identified by one of us (TK). Voucher specimens (TK-
PSKKU-0084) are on files in the Herbarium of the Faculty of
Pharmaceutical Sciences, Khon Kaen University.
Rha
1"
5.21 (1H, d, J = 1.7 Hz)
3.97 (1H, dd, J = 3.3, 1.7 Hz)
3.63 (1H, dd, J = 9.4, 3.3 Hz)
102.7
72.2
72.0
73.9
70.1
17.7
2"
3"
4"
5"
3.93 (1H, m)
6"
0.92 (3H, d, J = 6.2 Hz)
3.3. Extraction and isolation
Glc
1'"
2'"
3'"
4'"
5'"
6'"
4.47 (1H, d, J = 7.8 Hz)
3.25 (1H, dd, J = 8.9, 7.8 Hz)
3.35 (1H, dd, J = 8.9, 8.8 Hz)
104.6
75.0
78.2
71.5
78.1
62.5
The air dried leaves of M. sirindhorniae (2.3 kg) were extracted three
times with MeOH, and concentrated to dryness. The greenish residue
(331.4 g) was suspended in H2O and partitioned with Et2O. The water
soluble part (173.8) was subjected to a Diaion HP-20 column, and
eluted with H2O, and MeOH, successively. The fraction eluted with
MeOH (75.2 g) was applied to a silica gel column using solvent systems
EtOAc (4.0 L), EtOAc-MeOH (9:1, 12.0 L), EtOAc-MeOH-H2O (40:10:1,
12.0 L), EtOAc-MeOH-H2O (70:30:3, 8.0 L) and EtOAc-MeOH-H2O
(6:4:1, 7.0 L), respectively to provide six fractions (A to F).
3.32 (1H, m)
3.89 (1H, dd, J = 11.9, 1.8 Hz)
3.64 (1H, dd, J = 11.9, 5.0 Hz)
a
Chemical shifts were assigned by HMQC.
solvent system, H2O-MeOH (90:10 → 20:80, v/v) to provide 14 sub-
fractions. Sub-fraction E-8 was purified by preparative HPLC-ODS using
solvent system H2O-MeCN (85:15, v/v) to provide compounds 1
(18.9 mg) and 15 (44.6 mg). Finally, sub-fraction E-12 was purified by
preparative HPLC-ODS with solvent system H2O-MeCN (80:20, v/v) to
yield compounds 13 (35.9 mg) and 16 (21.9 mg).
Fraction B (4.9 g) was applies to a RP-18 column using a gradient
solvent system, H2O-MeOH (90:10 → 20:80, v/v) to provide 12 sub-
fractions. Sub-fraction B-5 was purified by preparative HPLC-ODS using
solvent system H2O-MeCN (83:17, v/v) to yield compound 9 (92.8 mg).
Sub-fraction B-7 was purified by preparative HPLC-ODS with solvent
system H2O-MeCN (77:23, v/v) to give compound 12 (47.7 mg).
Fraction C (22.5 g) was separated on a RP-18 column using solvent
system, H2O-MeOH (90:10 → 20:80, v/v) to provide 14 sub-fractions.
Sub-fraction C-1 was purified by preparative HPLC-ODS with solvent
system H2O-MeCN (90:10, v/v) to provide compounds 3 (17.7 mg), 5
(63.6 mg) and 7 (127.5 mg). Sub-fraction C-3 was purified by pre-
parative HPLC-ODS with solvent system H2O-MeCN (85:15, v/v) to
afford compounds 4 (81.5 mg) and 22 (389.8 mg). Sub-fraction C-4 was
purified by preparative HPLC-ODS with solvent system H2O-MeCN
(88:12, v/v) to obtain compound 2 (6.3 mg). Sub-fraction C-5 was
purified by preparative HPLC-ODS with solvent system H2O-MeCN
(83:17, v/v) to afford compound 10 (11.3 mg) and 11 (9.3 mg). Sub-
fraction C-8 was purified by preparative HPLC-ODS with solvent system
H2O-MeCN (80:20, v/v) to obtain compounds 18 (31.6 mg) and 21
(24.2 mg).
3.4. Benzyl O-α-L-rhamnopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]-
β-D-glucopyranoside (1)
27
Amorphous powder, [α]D −39.3 (MeOH, c 0.25); 1H and 13C
NMR (CD3OD): Table 1; Positive HRESITOFMS, m/z: 601.2104 [M
+Na]+ (C25H38NaO15 required 601.2103).
3.5. (7R)-campneoside I (10)
27
Amorphous powder, [α]D −36.2 (MeOH, c 0.16); 1H and 13C
NMR (CD3OD): Table 2; Positive HRESITOFMS, m/z: 653.2078 [M
+H]+ (C30H37O16 required 653.2087).
3.6. (7S)-campneoside I (11)
Fraction D (11.8 g) was applied to a RP-18 column using solvent
system, H2O-MeOH (90:10 → 20:80, v/v) to give 13 sub-fractions. Sub-
fraction D-1 was purified by preparative HPLC-ODS with solvent system
H2O-MeCN (92:8, v/v) to obtain compound 6 (161.2 mg). Sub-fraction
D-3 was purified by preparative HPLC-ODS with solvent system H2O-
MeCN (88:12, v/v) to provide compound 8 (50.8 mg). Sub-fraction D-5
was purified by preparative HPLC-ODS with solvent system H2O-MeCN
(83:17, v/v) to give compounds 14 (148.3 mg), 19 (44.9 mg) and 20
(27.6 mg). Sub-fraction D-7 was purified by preparative HPLC-ODS with
solvent system H2O-MeCN (83:17, v/v) to provide compound 17
(34.8 mg).
Amorphous powder, [α]D −16.2 (MeOH, c 0.13); 1H and 13C
27
NMR (CD3OD): Table 2; Positive HRESITOFMS, m/z: 653.2075 [M
+H]+ (C30H37O16 required 653.2087).
3.7. Determination of the absolute configuration of sugars of compound 1
Compound 1 (ca 3 mg) in 2 N HCl-dioxane (1:1, 3.0 mL) was heated
at 80 °C for 6 h. After cooling, each reaction was diluted with H2O and
extracted with EtOAc. The aqueous layer was concentrated to dryness
providing the sugar fraction. This fraction was dissolved in H2O
(1.0 mL), and analysed by HPLC (Jasco OR-2090 plus chiral detector;
Fraction E (23.5 g) was applies to a RP-18 column using a gradient
207